Diabetes Remission After RYGBP and RYGBP With Fundus Resection
Primary Purpose
Type 2 Diabetes, Morbid Obesity, Bariatric Surgery
Status
Completed
Phase
Not Applicable
Locations
Greece
Study Type
Interventional
Intervention
Laparoscopic Roux en Y gastric bypass
Laparoscopic Roux en Y gastric bypass with fundus resection
Sponsored by
About this trial
This is an interventional treatment trial for Type 2 Diabetes focused on measuring Gastric Fundus, Gastrointestinal Hormones
Eligibility Criteria
Inclusion Criteria: morbid obesity (ΒΜΙ ≥ 40) type II diabetes mellitus (T2DM) duration of T2DM shorter than 8 years Exclusion Criteria: pregnancy type 1 diabetes previous gastrointestinal surgeries alcohol consumption depression no compliance
Sites / Locations
- University of Patras, University Hospital of Patras
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Experimental
Arm Label
RYGBP
RYGBP + FR
Arm Description
Laparoscopic Roux en Y Gastric Bypass
Laparoscopic Roux en Y Gastric Bypass with fundus resection
Outcomes
Primary Outcome Measures
Diabetes remission in both groups
Change in HbA1c levels
Change in fasting and postprandial glucose levels
Glucose levels (mg/dl)
Change in insulin levels, fasting and postprandial
Insulin levels (μIU/ml)
Change in HOMA - IR
HOMA IR calculation with glucose (mg/dl) and insulin (mU/L)
Change in ghrelin levels
Fasting and postprandial ghrelin levels (pg/ml)
Change in GLP-1 levels
Fasting and postprandial GLP-1 levels (pg/ml)
Change in PYY levels
Fasting and postprandial PYY levels (ng/ml)
Change in glucagon levels
Fasting and postprandial glucagon levels (pg/ml)
Secondary Outcome Measures
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT05854875
Brief Title
Diabetes Remission After RYGBP and RYGBP With Fundus Resection
Official Title
RYGBP vs RYGBP With Fundus Resection for Morbid Obese Patients With Type 2 Diabetes. Evaluation of the Gastric Fundus in Glycemic Control. A Randomized Clinical Trial.
Study Type
Interventional
2. Study Status
Record Verification Date
May 2023
Overall Recruitment Status
Completed
Study Start Date
September 22, 2019 (Actual)
Primary Completion Date
March 2, 2023 (Actual)
Study Completion Date
April 10, 2023 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Patras
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
The goal of this randomized clinical trial is to evaluate glycemic control in patients with morbid obesity and type 2 diabetes after Roux-en-Y gastric bypass (RYGBP) and RYGBP with fundus resection. The main questions to answer are:
Rate of diabetes remission and the role of the gastrointestinal hormones
Whether fundus resection leads to improved glycemic control
Patients will randomly undergo typical RYGBP or RYGBP with fundus resection. Gastrointestinal hormones profile [ghrelin, glucagon-like peptide-1 (GLP-1), peptide YY (PYY), glucagon], glucose levels and insulin response will be measured preoperatively, at 6 months and at 12 months, during 120-min OGTT.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Type 2 Diabetes, Morbid Obesity, Bariatric Surgery
Keywords
Gastric Fundus, Gastrointestinal Hormones
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
24 (Actual)
8. Arms, Groups, and Interventions
Arm Title
RYGBP
Arm Type
Active Comparator
Arm Description
Laparoscopic Roux en Y Gastric Bypass
Arm Title
RYGBP + FR
Arm Type
Experimental
Arm Description
Laparoscopic Roux en Y Gastric Bypass with fundus resection
Intervention Type
Procedure
Intervention Name(s)
Laparoscopic Roux en Y gastric bypass
Intervention Description
Laparoscopic RYGBP included the creation of a small gastric pouch, with a 200cm biliopancreatic limb and a 150cm alimentary limb.
Intervention Type
Procedure
Intervention Name(s)
Laparoscopic Roux en Y gastric bypass with fundus resection
Intervention Description
Laparoscopic RYGBP included the creation of a small gastric pouch, with a 200cm biliopancreatic limb and a 150cm alimentary limb. Fundus resection is further applied in this arm.
Primary Outcome Measure Information:
Title
Diabetes remission in both groups
Description
Change in HbA1c levels
Time Frame
At 6 months and 12 months postoperatively
Title
Change in fasting and postprandial glucose levels
Description
Glucose levels (mg/dl)
Time Frame
At 6 months and 12 months postoperatively
Title
Change in insulin levels, fasting and postprandial
Description
Insulin levels (μIU/ml)
Time Frame
At 6 months and 12 months postoperatively
Title
Change in HOMA - IR
Description
HOMA IR calculation with glucose (mg/dl) and insulin (mU/L)
Time Frame
At 6 months and 12 months postoperatively
Title
Change in ghrelin levels
Description
Fasting and postprandial ghrelin levels (pg/ml)
Time Frame
At 6 months and 12 months postoperatively
Title
Change in GLP-1 levels
Description
Fasting and postprandial GLP-1 levels (pg/ml)
Time Frame
At 6 months and 12 months postoperatively
Title
Change in PYY levels
Description
Fasting and postprandial PYY levels (ng/ml)
Time Frame
At 6 months and 12 months postoperatively
Title
Change in glucagon levels
Description
Fasting and postprandial glucagon levels (pg/ml)
Time Frame
At 6 months and 12 months postoperatively
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
morbid obesity (ΒΜΙ ≥ 40)
type II diabetes mellitus (T2DM)
duration of T2DM shorter than 8 years
Exclusion Criteria:
pregnancy
type 1 diabetes
previous gastrointestinal surgeries
alcohol consumption
depression
no compliance
Facility Information:
Facility Name
University of Patras, University Hospital of Patras
City
Patras
State/Province
Rio
ZIP/Postal Code
26504
Country
Greece
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Diabetes Remission After RYGBP and RYGBP With Fundus Resection
We'll reach out to this number within 24 hrs